tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kristen Kluska, 200 are a BUY (91.74%), 18 are a HOLD (8.26%).
Analyst Kristen Kluska, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 32.4% that have a potential upside of 32.95% achieved within 83 days.
Kristen Kluska’s has documented 424 price targets and ratings displayed on 35 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on PTCT, PTC Therapeutics at 29-Jul-2025.
Analyst best performing recommendations are on OCGN (OCUGEN).
The best stock recommendation documented was for OCGN (OCUGEN) at 2/3/2021. The price target of $4 was fulfilled within 2 days with a profit of $1.19 (42.35%) receiving and performance score of 211.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$50
$28.02 (127.48%)
$50
1 months 20 days ago
(16-Jun-2025)
6/32 (18.75%)
$29.66 (145.82%)
256
Buy
$67
$45.02 (204.82%)
$67
6 months 7 days ago
(29-Jan-2025)
4/18 (22.22%)
$41.49 (162.64%)
62
Hold
$37
$15.02 (68.33%)
$35
11 months 24 days ago
(12-Aug-2024)
4/4 (100%)
$3.54 (10.58%)
165
Buy
$90
$68.02 (309.46%)
$72
1 years 5 months 9 days ago
(27-Feb-2024)
0/4 (0%)
$38.96 (76.33%)
Buy
$68
$46.02 (209.37%)
$70
1 years 11 months 25 days ago
(11-Aug-2023)
0/3 (0%)
$37.77 (124.94%)
Which stock is Kristen Kluska is most bullish on?
Which stock is Kristen Kluska is most reserved on?
What Year was the first public recommendation made by Kristen Kluska?
